Harbin Medisan Pharmaceutical Co., Ltd. approved the cash dividend of CNY 1.00 (tax included) per 10 A shares for the year 2022, at the AGM held on May 16, 2023 with an ex-date of May 31, 2023, record date on May 30, 2023 and payment date on May 31, 2023. Net cash dividend/10 shares after tax: CNY 0.90000000 (CNY 1.00000000 - CNY 0.10000000).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.75 CNY | -2.71% | +5.19% | -21.25% |
Apr. 26 | Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
Apr. 26 | Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation | MT |
1st Jan change | Capi. | |
---|---|---|
-21.25% | 472M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022, Payable on May 31, 2023